Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
1.285
+0.025 (1.98%)
Jul 24, 2026, 9:42 AM EDT - Market open
Daré Bioscience Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 |
Net Income | -3 | -1.44 | -3.56 | -4.02 | -4.38 | -5.51 | -4.7 | 12.91 | -6.76 | -5.06 | -8.3 | -8.76 | -8.04 | -15.94 | -7.02 | 0.41 | -8.4 | -9.54 | -12.67 | -9.16 |
Depreciation & Amortization | 0.55 | 0.53 | 0.48 | 0.46 | 0.18 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Stock-Based Compensation | 0.46 | 0.36 | 0.4 | 0.36 | 0.38 | 0.49 | 0.52 | 0.56 | 0.63 | 0.62 | 0.64 | 0.65 | 0.62 | 0.53 | 0.56 | 0.54 | 0.53 | 0.39 | 0.44 | 0.41 |
Other Adjustments | 0.14 | -0 | 0.32 | 0.26 | 0.11 | 0.06 | 0.16 | 0.2 | 0.8 | -1.11 | 0.09 | 0.09 | 0.09 | -0.01 | 0.02 | 0.02 | -0.01 | -0.03 | -0.02 | -0.02 |
Change in Receivables | -0.11 | -0.2 | -0.19 | -0.08 | 0.12 | 0.3 | 0.37 | 0.48 | -0.44 | 0.18 | -0.56 | -0.71 | -0.7 | 0.59 | -0.15 | -0.41 | -0.58 | -0.99 | 2.8 | -2.65 |
Changes in Accounts Payable | -0.04 | -0.62 | 0.52 | -0.12 | -0.03 | 0.41 | -0.86 | -2.13 | 0.65 | -1.6 | -1.55 | 3.85 | 0.67 | -1.45 | 2.36 | -1.72 | 0.73 | 1.5 | 0.39 | -1.26 |
Changes in Accrued Expenses | -0.01 | -1.24 | -0.62 | 0.7 | -1.08 | 1.38 | 0.16 | -0.05 | -1.32 | -2.2 | 0.63 | -1.29 | -5.41 | 6.76 | -2.21 | 2.81 | 0.4 | -0.64 | -0.42 | 1.85 |
Changes in Other Operating Activities | -3.5 | 5.17 | 2.25 | -2.97 | -0.77 | 7.47 | -1.06 | 0.09 | -0.4 | 0.36 | 1.07 | -1.81 | -3.36 | 3.69 | 5.09 | -0.11 | -5.02 | -0.61 | 10.75 | -0.96 |
Operating Cash Flow | -5.52 | 1.44 | -0.44 | -5.42 | -5.47 | 5.31 | -5.92 | 12.9 | -6.81 | -8.18 | -7.97 | -6.59 | -16.12 | -5.9 | 8.6 | -8.45 | -12.34 | -9.92 | 1.32 | -11.79 |
Operating Cash Flow Growth | - | -72.78% | - | - | - | - | - | - | - | - | - | - | - | - | 551.37% | - | - | - | - | - |
Capital Expenditures | - | -0.21 | -0.17 | 0.15 | -0.16 | -0.56 | 0.28 | -0.29 | -0.01 | -0.61 | -0.02 | - | - | -0 | -0.06 | -0 | -0 | 0 | -0.01 | - |
Investing Cash Flow | - | -0.21 | -0.17 | 0.15 | -0.16 | -0.56 | 0.28 | -0.29 | -0.01 | -0.61 | -0.02 | - | - | -0 | -0.06 | -0 | -0 | 0 | -0.01 | - |
Long-Term Debt Issued | - | 0 | - | - | - | 0 | - | - | - | 0 | - | - | - | - | - | - | - | - | - | - |
Long-Term Debt Repaid | -0.18 | -0.18 | -0.12 | -0.06 | -0.19 | -0.19 | -0.13 | -0.07 | -0.2 | -0.2 | -0.13 | - | - | - | - | - | - | - | - | - |
Net Long-Term Debt Issued (Repaid) | -0.18 | -0.18 | -0.12 | -0.06 | -0.19 | -0.19 | -0.13 | -0.07 | -0.2 | -0.2 | -0.13 | - | - | - | - | - | - | - | - | - |
Issuance of Common Stock | 0.09 | 1.27 | 18.74 | 0.48 | 0.44 | 0.06 | 0 | 0.18 | 0.22 | 4.45 | 4.45 | 0.45 | 1.3 | -0 | -0.12 | 0.12 | - | 15.5 | 35.22 | 13.25 |
Net Common Stock Issued (Repurchased) | 0.09 | 1.27 | 18.74 | 0.48 | 0.44 | 0.06 | 0 | 0.18 | 0.22 | 4.45 | 4.45 | 0.45 | 1.3 | -0 | -0.12 | 0.12 | - | 15.5 | 35.22 | 13.25 |
Issuance of Preferred Stock | 0.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Preferred Stock Issued (Repurchased) | 0.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Other Financing Activities | -0.93 | -0.35 | -0.46 | -0.46 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Financing Cash Flow | -0.72 | 0.42 | 18.65 | -0.04 | 0.25 | -0.13 | 0.44 | 0.12 | 0.01 | 5.31 | 8.58 | 0.45 | 1.3 | -0 | 0 | 1.34 | - | 16 | 35.22 | 13.25 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 0.04 | -0.03 | 0.01 | 0.01 | 0.01 | -0.07 | 0.02 | 0.01 | -0.04 | 0.06 | -0.02 | -0.03 | -0.02 | 0.18 | -0.23 | -0.14 | -0.01 | 0.02 | -0.06 | -0.01 |
Net Cash Flow | -6.19 | 1.64 | 18.04 | -5.29 | -5.37 | 4.47 | -5.18 | 12.75 | -6.85 | -3.42 | 0.57 | -6.17 | -14.84 | -5.72 | 8.32 | -7.25 | -12.36 | 6.1 | 36.46 | 1.45 |
Free Cash Flow | -5.52 | 1.24 | -0.62 | -5.26 | -5.63 | 4.74 | -5.64 | 12.62 | -6.82 | -8.79 | -8 | -6.59 | -16.12 | -5.9 | 8.55 | -8.45 | -12.35 | -9.92 | 1.31 | -11.79 |
Free Cash Flow Growth | - | -73.91% | - | - | - | - | - | - | - | - | - | - | - | - | 554.40% | - | - | - | - | - |
FCF Margin | -3621.16% | 120.90% | -27269.50% | 24863.30% | -22133.50% | -7452.15% | -13532.30% | 56241.50% | -73320.30% | -486.00% | -799.59% | - | - | - | - | -84.49% | - | - | - | - |
Free Cash Flow Per Share | -0.38 | 0.09 | -0.05 | -0.59 | -0.64 | 0.59 | -0.66 | 1.49 | -0.81 | -1.20 | -1.05 | -0.91 | -2.26 | -0.85 | 1.21 | -1.19 | -1.77 | -1.49 | 0.22 | -2.81 |
Levered Free Cash Flow | -6.18 | 2.01 | -1.22 | -5.86 | -6.43 | 3.01 | -6.29 | 10.48 | -8.02 | -9.3 | -8.3 | -8 | -16.14 | -6.94 | -1.83 | 1.4 | -12.29 | -9.29 | -1.95 | -9.52 |
Unlevered Free Cash Flow | -6 | 2.16 | -1.21 | -5.61 | -6.44 | 3.32 | -6.15 | -9.72 | -7.08 | -9.21 | -8.27 | -8.23 | -16.48 | -7.22 | -1.95 | 1.37 | -12.29 | -9.29 | -1.95 | -9.52 |